Home
About
Pricing
Log In
Back
ADAP
Asset Logo

Adaptimmune Therapeutics plc American Depositary Shares

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-19.83%
Annual Growth

5 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Adaptimmune Therapeutics PLC is focused on pre-clinical programs, including PRAME and CD70-directed T-cell therapies, and its allogeneic pipeline. PRAME is highly expressed across a range of solid tumors, including ovarian, endometrial, lung and breast cancers. The CD70 program targets the CD70 antigen, which is expressed across a range of hematological malignancies (acute myeloid leukemia and lymphoma) and solid tumors (renal cell carcinoma). It is using TRuC technology to develop a T-cell therapy (ADP-520) against CD70, with membrane bound IL-15 to enhance persistence. ADP-520 is in pre-clinical testing. TRuC technology combines the targeting of CAR-T cells with T-cell TCR signaling.

📈 Performance

Price History*

-99.28%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.09

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ADAP

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

1 days

💵 Average investment amount

$63

Last time a customer invested in ADAP

378 days
ADAP investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in ADAP also invest in...

Gilead Sciences, Inc. Common Stock

GILD

🙌 Performance (5Yr p.a)

14.63%

📊 Share price

$112.65 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

6.00%

📊 Share price

$53.08 USD

🙌 Performance (5Yr p.a)

-8.97%

📊 Share price

$56.52 USD

🙌 Performance (5Yr p.a)

33.29%

📊 Share price

$70.98 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

-13.23%

📊 Share price

$13.06 USD

Want more shares? Try these...

Compare
Add to watchlist